Scarlett-Smith joins Stada
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Stada Arzneimittel has named OTC industry veteran Roger Scarlett-Smith as interim managing director of its Thornton & Ross UK operation with immediate effect. Scarlett-Smith – who will serve for a minimum period of six months – replaces Dieno George, who will retire from the company at the end of the year after four decades at the UK-based firm.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.